Brief: Cingulate Achieves Key Manufacturing Milestone In The Development Of Its Adhd Drug CTx-1301 In Preparation For FDA Marketing Clearance

Cingulate

25/06/2024 14:45

June 25 (Reuters) - Cingulate Inc  CING.O :
    * CINGULATE ACHIEVES KEY MANUFACTURING MILESTONE IN THE
DEVELOPMENT OF ITS ADHD DRUG CTX-1301 IN PREPARATION FOR FDA
MARKETING CLEARANCE
    * CINGULATE INC: BEGUN NDA PREPARATION AND EXPECTS TO SUBMIT
ITS
APPLICATION IN FIRST HALF OF 2025

Source text for Eikon:  ID:nGNX95KcnK 
Further company coverage:  CING.O 

 ((Reuters.Briefs@thomsonreuters.com;))